Anyone can submit a Yellow Card report for non-trial use, including: Patients and members of the public GPs, pharmacists, nurses, and hospital clinicians Parents or carers reporting on behalf of another person For general queries about medicines safety or to find out more about the Yellow Card Scheme, patients can contact the MHRA directly or speak to their GP or pharmacist
Company: MedisourceRx Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: December 12, 2025
After stopping semaglutide, TSH returned to baseline while T3 and T4 only partially returned to starting levels
[16] Interactions with certain metals also stabilize thiolate intermediates
The most common include: Nausea Vomiting Diarrhea Constipation Abdominal pain People taking Wegovy also reported headaches and fatigue in clinical trials
doi:10.5326/15473317-37-2-183